Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease (FRENCH)

This study has been completed.
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Centre Hospitalier Universitaire, Amiens Identifier:
First received: October 12, 2010
Last updated: April 27, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)